Optimizing strategies in tendon tissue engineering through effective scaffold design: overview of recent advancements Authors: Gabrielle Lynn Hamner, Justin Lee Brown Published: 2026 ABSTRACT ABSTRACTTendon injuries pose a significant global health challenge due to the poor innate healing capacity of the tissue. Current clinical interventions report limited treatment efficacy, typically resulting in a fibrotic scar that is mechanically inferior to native tissue and predisposed to future re-rupture. Tendon tissue engineering, leveraging advances of biomimetic scaffolds, offers a promising path toward functional regeneration rather than fibrotic repair. The design of these biomimetic scaffolds is a complex, interdisciplinary challenge that has evolved from a simple structural replacement to a sophisticated, bio-instructive strategy. Literature searches were conducted using PubMed, Scopus, and R Discovery with the terms “tendon tissue engineering scaffold” or “tendon regenerative medicine scaffold,” and studies published between 2020 and 2025 were included. In this review, we outline four key design principles identified to enhance tissue engineering solutions constructed for tendon: 1) Biomechanical compatibility, 2) Biocompatibility and Integration, 3) Porosity and Mass Transport, and 4) Mechanobiological Stimuli. Together, these core parameters mediate the production of hierarchical, bio-instructive scaffolds that integrate cellular components, growth factors, and mechanical stimulation to produce intelligent therapeutic systems for functional, long-lasting tendon regeneration. Introduction Tendons are an essential connective tissue that facilitate the transfer force from muscle to bone, movement, and enforce articular stability. Their unique biomechanical capabilities arise from their hierarchical structure, composed predominantly of Type I collagen, which provides strength and flexibility crucial to fulfill their biological function. Within the tissue, tendon specific fibroblastic cells exist in various states of maturation, which progress from tendon stem/progenitor cells (TSPCs), tenoblasts, to tenocytes, which are embedded within a dense three-dimensional extracellular matrix (ECM). Due to tendon tissue’s hypocellular and avascular nature, once injured biomechanical properties, like strength and flexibility, rarely restore to full function on their own. After acute injury, tendons typically heal via the production of a disorganized fibrotic scar, which fails to match the structural organization and biomechanical properties of native tendons. As a result, patients typically present with weakness, pain, reduction in motility, and a predisposition to future re-rupture. Surgical intervention, with native, synthetic, or xeno grafts, has long been considered the gold standard in treatment, but presents limited efficacy, motivating the need for novel tissue engineering and regenerative medicine solutions. This review examines key strategies for optimizing tendon scaffold design. Literature searches were conducted using PubMed, Scopus, and R Discovery databases with the terms “tendon tissue engineering scaffold” or “tendon regenerative medicine scaffold.” The search strategy employed combinations of key terms, including “enthesis,” “tendinopathy,” “mechanotransduction,” “nanofibers,” “microfibers,” “3D printing,” “micropatterning,” and “electrospinning.” Backward citation tracking was performed on all included papers and key reviews identified during the initial search phase. Applicable studies published between 2020 and 2026 were included. Prevalence of tendon injuries Tendon injuries occupy approximately 50% of musculoskeletal injuries in the United States, with more than 102.5 million adults affected by serious tendon injuries from sports or repetitive activities annually [1–6]. Tendons are often injured in one of two ways: progressive overloading or single vigorous impact. Acute ruptures of tendons frequently occur in the Achilles [7–12], quadricep [13,14], patellar [13,15,16], distal biceps [17,18], rotator cuff [19–21], and flexor or extensor tendons [22–25]. Over the last number of years, tendon injuries and ruptures have only increased, and with an active and aging population, this trend is likely to continue [26]. Table 1 is a compilation of published yearly incidence rates (reported in 100,000 people/year) of the aforementioned tendon ruptures for global and United States demographics, as well as their average re-rupture rates.Table 1.Tendon incidence rate ranges for global and US populations reported in 100,000 people/year, including re-rupture rates and demographic. Incidence rates were collected from published literature values referenced accordingly.TendonGlobal Incidence rate (100,000 people/year)United States incidence rate (100,000 people/year)Re-Rupture rateDemographicReferencesRotator Cuff(Shoulder)15–1650.35 (acute ED visits) 165.0 (Surgical repairs)5% patients <50 years old; 10% 50–59 years; 15% 60–69 years; 25% 70–79 years; 25% >80 yearsIncidence and re-rupture strongly correlate with age. Rates reach up to 50% when including asymptomatic tears found via imaging in populations aged 60+ years[1,19–21,26]Achilles(Ankle)6 to 402.5 to 242.3–4% surgical treatment; 3.9%–12% non-surgical treatment65%+ Male; Males 30–39; Females age 45–49[1,2,5,7–12]FlexorDigitorum(Hand)4.0 to 7.4~144–17%20–29 years; high association with manual labor utilizing knives[1,5,22,24,25]Extensor Digitorum (Wrist)14.6 to 21.9~190–1.2%Males 20–29; 25% work related[1,5,22,24,25]Patellar(Knee)∼0.7 to 1.00.48 (ED visits) to 6.0 (US Military)3%–50% (Varies widely depending on repair technique and context)Commonly sports related and occur before age 40; Active US Military responsible for higher 6.0 incidence rate[1,15,16]Distal Biceps(Arm)1.2 to 9.60.68 (ED visits) to 2.55 (General population)1.5%–5.4% (Typically low after primary surgical repair)>95% males; 35–54 years old[1,5,17,18]Quadriceps(Thigh)∼0.5 to 2.80.31 (ED visits)2%–11% (Pooled surgical repair re-rupture rate)Male to female ratio of 8:1 and likelihood of rupture increases with age after 40 years[1,5,13,14] Table 1.Tendon incidence rate ranges for global and US populations reported in 100,000 people/year, including re-rupture rates and demographic. Incidence rates were collected from published literature values referenced accordingly.TendonGlobal Incidence rate (100,000 people/year)United States incidence rate (100,000 people/year)Re-Rupture rateDemographicReferencesRotator Cuff(Shoulder)15–1650.35 (acute ED visits) 165.0 (Surgical repairs)5% patients <50 years old; 10% 50–59 years; 15% 60–69 years; 25% 70–79 years; 25% >80 yearsIncidence and re-rupture strongly correlate with age. Rates reach up to 50% when including asymptomatic tears found via imaging in populations aged 60+ years[1,19–21,26]Achilles(Ankle)6 to 402.5 to 242.3–4% surgical treatment; 3.9%–12% non-surgical treatment65%+ Male; Males 30–39; Females age 45–49[1,2,5,7–12]FlexorDigitorum(Hand)4.0 to 7.4~144–17%20–29 years; high association with manual labor utilizing knives[1,5,22,24,25]Extensor Digitorum (Wrist)14.6 to 21.9~190–1.2%Males 20–29; 25% work related[1,5,22,24,25]Patellar(Knee)∼0.7 to 1.00.48 (ED visits) to 6.0 (US Military)3%–50% (Varies widely depending on repair technique and context)Commonly sports related and occur before age 40; Active US Military responsible for higher 6.0 incidence rate[1,15,16]Distal Biceps(Arm)1.2 to 9.60.68 (ED visits) to 2.55 (General population)1.5%–5.4% (Typically low after primary surgical repair)>95% males; 35–54 years old[1,5,17,18]Quadriceps(Thigh)∼0.5 to 2.80.31 (ED visits)2%–11% (Pooled surgical repair re-rupture rate)Male to female ratio of 8:1 and likelihood of rupture increases with age after 40 years[1,5,13,14] Tendon incidence rate ranges for global and US populations reported in 100,000 people/year, including re-rupture rates and demographic. Incidence rates were collected from published literature values referenced accordingly. Rupture sites are often where the force and biomechanical stress concentrations are highest, making them more susceptible to rupture under strain or repetitive stress. Achilles tendon ruptures often occur in the midsubstance, approximately 2–6 cm above the calcaneus bone, an area known for reduced capillary oxygenation and perfusion [7,10]. The quadriceps tendon often ruptures within 2 cm from the patella bone, in the transition zone known as the enthesis [14]. The patellar, distal bicep [17,18], and rotator cuff [21,27] tendons also commonly ruptured at the insertion or interface where the tendon attaches to its anchor bone, the patella, radius, and humeral head, respectively. Current treatment strategies Although impressive strides have been made in tissue engineering, clinical therapy for tendon injuries remains largely unchanged, either conservative or surgical treatment strategies. Conservative treatment usually entails physiotherapy alongside pharmacological or stem cell-based injections. Surgical treatment can include sutures with an autologous graft (autograft), allograft, or artificial graft transplantation, and tendon-to-bone fixation. Autografts are considered the “gold standard” for tendon repair, but require two surgical sites, increasing operation and recovery time, as patients must heal both rupture and donor sites simultaneously. Allografts circumvent the second operation site by using a different donor source, but that can leave openings for a mismatch in age, gender, or body weight between the donor and recipient, immunological rejection, and disease transmission. Each complication increases the likelihood of fibrotic healing and re-rupture rates. These concerns have motivated the rise of tissue engineering solutions, leveraging novel scaffold strategies to promote enhanced regenerative outcomes. The primary goal of these scaffolds is to create a microenvironment that actively biases the cellular response away from the fibrotic, scar-associated healing pathway and toward a regenerative one. Tendon formation and repair As stability, weight transfer, and facilitation of movement are tendons’ prime duties within the body; their shapes must be just as dynamic as their functions. This “form supporting function” phenomenon is crucial as tendons are specially adapted to their physiological function and anatomical location. Tendon strength and resistance are influenced by their diameter and length, which is directly affected by the arrangement and size of their collagen fibrils. Fine motor muscles often have long and thin tendons, while those for power and endurance have shorter, more robust ones. Insertion sites of tendons follow the same rules and are also adapted to the specific forces their tendons transmit. Tendons can be classified by function into three distinct types: force-transmitting, intermuscular, and anchor. Force-transmitting tendons are long chords or rope-like tendons, organized in tight parallel collagen fibers, that transmit muscle forces to facilitate movement [28]. Intermuscular tendons connect two muscle segments, while anchor tendons secure the muscle to their respective bone insertion. Classifications of commonly ruptured tendons type, structure, and anatomical location are summarized in Table 2.Table 2.Properties of commonly ruptured tendons including tendon type, structure, and function in human anatomy.TendonTypeStructureFunctionReferencesRotator Cuff(Shoulder)AnchorFlattened, broad bandsStabilizes the shoulder joint, holds the arm in the ball and socket joint, and enables a wide range of arm movements. Can withstand compression and shear forces.[19–21]Achilles (Ankle)ForceTransmittingRounded, thick cordLong (15–26 cm), thickest and strongest tendonTransmits force of calf muscles to heel bone (e.g., plantar flexion- pointing foot downward), supports large forces (up to 10x body weight), crucial for walking, running, jumping, and standing on tiptoes.[2,7–12]Flexor/Extensor(Hand and Wrist)Force transmittingLong & thin, flattened or rounded chordsEnable fine, delicate movements of fingers (Flexor: Bending fingers and thumb toward the palm) (Extensor: extend and straighten)[22,24,25]Patellar(Knee)Force transmitting5 cm long, 25 mm wide, Single thick, fibrous chord, with parallel fibersTransmits force from quadriceps muscle to tibia, part of the knee extensor mechanism. Supports body weight during activities.[15,16]Distal Biceps (Arms)IntermuscularY shaped structure; average length 9 cm;Attaches the biceps muscle to radial bone; Facilitates elbow flexion and forearm supination[17,18]Quadriceps(Thigh)IntermuscularRope-like fibrous tissueConnects quadriceps muscle to top of the patella (kneecap), needed to straighten knee and raise leg[13,14] Table 2.Properties of commonly ruptured tendons including tendon type, structure, and function in human anatomy.TendonTypeStructureFunctionReferencesRotator Cuff(Shoulder)AnchorFlattened, broad bandsStabilizes the shoulder joint, holds the arm in the ball and socket joint, and enables a wide range of arm movements. Can withstand compression and shear forces.[19–21]Achilles (Ankle)ForceTransmittingRounded, thick cordLong (15–26 cm), thickest and strongest tendonTransmits force of calf muscles to heel bone (e.g., plantar flexion- pointing foot downward), supports large forces (up to 10x body weight), crucial for walking, running, jumping, and standing on tiptoes.[2,7–12]Flexor/Extensor(Hand and Wrist)Force transmittingLong & thin, flattened or rounded chordsEnable fine, delicate movements of fingers (Flexor: Bending fingers and thumb toward the palm) (Extensor: extend and straighten)[22,24,25]Patellar(Knee)Force transmitting5 cm long, 25 mm wide, Single thick, fibrous chord, with parallel fibersTransmits force from quadriceps muscle to tibia, part of the knee extensor mechanism. Supports body weight during activities.[15,16]Distal Biceps (Arms)IntermuscularY shaped structure; average length 9 cm;Attaches the biceps muscle to radial bone; Facilitates elbow flexion and forearm supination[17,18]Quadriceps(Thigh)IntermuscularRope-like fibrous tissueConnects quadriceps muscle to top of the patella (kneecap), needed to straighten knee and raise leg[13,14] Properties of commonly ruptured tendons including tendon type, structure, and function in human anatomy. Although the shape and size of tendons can vary, the bulk of the composition does not. Normal human tendon is primarily made up of collagen type I (COL1), as it makes up 65–80% of dry tendon mass, with water making up 70% of the total tendon mass [29]. Type I Collagen fibers also follow a hierarchal structure and contain two α1 chains (COL1A1) and one α2 chain (COL1A2) intertwined. Following the cleavage of the C- and N- pro-collagen ends, tropocollagen spontaneously self-assembles into a highly organized structure known as microfibrils. Microfibrils form fibrils, fibrils make up fibers, fibers bundle into fascicles, and bundled fascicles create the endotenon encased in the epitenon [30–32]. The remaining 20–35% of dry tendon composition includes elastin, proteoglycans, and glycoproteins, important in tissue mechanics, resistance to compression, and collagen fibrilogenesis and tendon integrity [33]. As shown in Figure 1, the repetition of interconnected bundles creates crimping, first in the collagen fibrils, and then after fibrils are bundled, the resulting fibers have a crimp waveform. This highly aligned ‘crimp pattern’ allows the tendon to distend and absorb large forces and provide a buffer during the initial stages of mechanical loading, an essential structural characteristic needed to fulfill their function. This biomechanical response is best displayed via stress-strain curve (Figure 1(b)), which features a “toe region” as a nonlinear response between 0% and 2% strain. After 2% strain, the crimped fibers straighten at a linear rate until 4% strain is reached. Beyond 4% strain is where fibers begin to micro-rupture and irreversible plastic deformation can occur and lead to macro-rupture [34]. Figure 1.Hierarchical structure of tendons (A) and (B) their stress-strain profile. Figure made with Mind the Graph.The image A showing the hierarchical structure of tendons, illustrating the progression from fibril to tendon. The fibril is labeled with a size range of 1.5 nanometers, followed by the fiber ranging from 50 to 500 nanometers, the fascicle from 10 to 50 micrometers and finally the tendon from 500 to 2000 micrometers. The image B showing a stress-strain graph for tendons. The x-axis is labeled 'Strain' in percent, ranging from 0 to 8 percent and the y-axis is labeled 'Stress' in newtons per millimeter squared. The graph features three regions: the toe region from 0 to 2 percent strain, where crimped fibers straighten; the linear region from 2 to 4 percent strain, indicating microscopic failure; and the yield and failure region beyond 4 percent strain, showing rupture and macroscopic failure. The physiological range is marked within the toe and linear regions.Illustration of tendon structure and stress-strain profile with two sub-images. Hierarchical structure of tendons (A) and (B) their stress-strain profile. Figure made with Mind the Graph. Tendon formation Tendon formation relies on a combination of transcription factors, growth factors, and mechanical stimulation to properly develop [35–37]. It all begins with human mesenchymal stem cells (hMSCs) that differentiate into tendon progenitor cells (TPCs), which further differentiate into tenoblasts and then mature into tenocytes. Each cell stage plays an important role in tendon formation and extracellular matrix (ECM) regulation. ECM production and turnover are key components of tendon homeostasis; without the architectural arrangement of cross-linked ECM components, tendons cannot sustain the necessary load to function properly [38,39]. Mechanical stimulation promotes membrane stretch, which in turn triggers mechanotransduction cascades. Mechanotransduction enables cells to translate mechanical forces into biochemical signals that can stimulate cell migration and differentiation, tissue growth, or macrophage polarization. The differentiated tenocytes are reinforced by this movement as it provokes the cells into replenishing the ECM, strengthening the tissue, and maintaining homeostasis [40]. Connective tissues, including tendons and ligaments, highly express Scleraxis (Scx) in progenitor cells, a transcription factor identified as one of the earliest detectable markers for tendon differentiation, which also persists throughout the process of tendon development [28,41,42]. Scleraxis can be considered an upstream gene that regulates the function of important proteins like Fibromodulin (Fmod) and Tenomodulin (Tnmd) [28,41,43,44]. Tenomodulin (Tnmd) is a terminal tendon-related marker prevalent in mature tenocytes that influences ECM structure and organization and the expression of key cross-linking enzymes of collagen I fibers [28,41]. The induction of Scx is controlled by the Fibroblast Growth Factor (FGF), Transforming Growth Factor β (TGFβ), and Wingless-related integration site (Wnt) signaling pathways [41,45]. Mechanical stimulation regulates FGF and TGFβ signaling pathways, but tension regulates Scx better than compression or other mechanical stimulations [46]. While Scx is considered the first signaling molecule in TPC initiation, Mohawk (Mkx) and early growth response 1 and 2 (Egr1, Egr2) are secondary. Mkx is a gene expressed in developing tendon cells, that is involved with the regulation of lumican, decorin, and Fibromodulin (Fmod), proteoglycans known for their roles in mechanical support, ECM stability, as well as binding and organizing collagen fibrils [28]. Egr1 and Egr2 are transcription factors, also activated through the mechanosensitive FGF signaling pathway, and are shown to stabilize COL1a1 expression and collagen fibril numbers [28,29]. Erg1 has been shown to increase the expression of Scx, Tnmd, Dcn, and COL1a1 in tendon progenitor cells [47,48]. The mechanosensitive nature of tendon cells extends to ion channels and proteins in the Piezo Family. Piezo proteins are mechanosensitive ion channels embedded into the cell membrane that convert mechanical stimuli into biochemical signals, through the same mechanism as growth factor deployment, mechanotransduction. Piezo channels, particularly PIEZO1 (PIEZO1-MKX/SCX cascade) [35,36], are important in tendons as PIEZO1 responds directly to membrane stretch [40]. PIEZO1 transitions from a curved state to a flattened one, which opens its central pore and leads to an influx of extracellular cations such as Ca2+, Na+, and K+ [49,50]. These ions, Ca2+ in particular, act as second messengers to activate various intracellular signaling pathways, YAP/TAZ, MAPK/ERK, and NFAT, to regulate processes like cell differentiation. In tendon, mechanical forces were found to trigger Ca+2 influx [51]. Piezo1ten-mut/+ mice had larger diameter collagen fibrils compared to WT mice, 1.3-fold larger in males and 1.2-fold larger in females. Gene expression profiles showed a significant upregulation of tendon-related genes, including Scx, Mkx, Tnmd, Dcn, and COL1a1, in Piezo1ten-mut/+ mice compared to WT [51]. After Nuclear Factor of Activated T-cells (NFAT) knockdown experiments, the results suggest that PIEZO1 induces the nuclear translocation of multiple cytoplasmic NFATs through the activation of calcineurin via Ca2+ influx, which regulates Mkx and Scx expression. Taken together, this study suggests that PIEZO1 enhances tendon tissue formation and promotes tendon enlargement [51]. Tendon repair after injury Tendon formation and repair are two different processes that both greatly depend on the patient’s age. Adult tendon injury is often correlated with a scar-associated healing process, which is a response composed of three overlapping stages: 1) Inflammation, 2) Proliferation, 3) Remodeling (Figure 2) [28,36]. Shortly after injury, the Inflammatory stage begins, which lasts approximately 2 days, as the injured area is infiltrated with erythrocytes, leukocytes, and platelets secreting inflammatory cytokines including IL-6, IL-β, and TNF-α [37,52]. Necrotic segments are phagocytosed by macrophages, and fibrin clots are assembled to fortify the injured tissue. Tendon stem/progenitor cells (TSPCs) migrate to the injured region to induce the second stage of healing. The second stage is the Repair or Proliferative stage, in which macrophages are encouraged to change roles from phagocytosis to reparation as they synthesize and release growth factors. Tenocytes’ arrival at the injury site begins fibroblast and inflammatory cell recruitment to help deposit ECM, mainly comprised of transient collagen III and bFGF, to promote cellular proliferation and angiogenesis. Angiogenesis is initiated by VEGF expression and the need to recruit nutrients and cells to the injured region. After 1–2 months post-injury, the third stage, Remodeling, begins and can continue for more than a year. Collagen I is synthesized as the ECM continues to be deposited and becomes more organized at the injury site, but fails to recapitulate the hierarchical structure-function capabilities of native collagen [37,52]. Figure 2.Tendon healing stages: inflammatory, proliferative, and remodeling. Figure made with BioRender.The illustration depicts the stages of tendon healing. The first section shows the inflammatory phase lasting 3 to 7 days, highlighting immune cell migration with tenocytes, neutrophils and macrophages. Inflammatory cytokines such as IL-6, IL-1 beta and TNF-alpha are present, with a transition from M1 to M2. The second section illustrates the proliferative phase lasting 4 to 6 weeks, focusing on angiogenesis, cellular proliferation and matrix deposition. Tendon stem or progenitor cells, collagen III and VEGF are involved. The final section represents the remodeling phase, emphasizing scar healing with collagen I, Scx, TGF beta and MMP. Each phase is marked by specific cellular activities and molecular expressions essential for tendon repair.Illustration of tendon healing stages: inflammatory, proliferative and remodeling phases with cellular activities. Tendon healing stages: inflammatory, proliferative, and remodeling. Figure made with BioRender. Scaffold design strategies Rational design An ideal scaffold for tendon tissue engineering must satisfy a complex set of engineering and biological criteria to achieve functional regeneration and successful clinical translation. One critical focus of tendon scaffold engineering is biomimicry [32,53–55]. The scaffold’s physical structure is designed with tendon’s ultrastructural organization as the blueprint, providing cues that guide cell attachment, proliferation, and alignment [53]. Biomimicry is not merely aesthetic, but a bio-instructive strategy. Scaffolds engineered to mimic the topographical cues of tendon tissue have proven a template for “contact guidance,” a phenomenon where the aligned fibers direct the morphology of cells cultured on them [56,57]. Surface topography refers to the micro- and nanoscale features on the scaffold surface, which can dramatically affect stem cell adhesion, proliferation, and differentiation. Surface patterns can influence the organization of membrane proteins and the cytoskeleton, which are pivotal in mechanosensitive signaling pathways and differentiation processes [35,37,58,59]. As mentioned above, tendon fibroblasts are highly mechanosensitive and have been shown to align in parallel arrangement when in contact with aligned nanofibers, mirroring their orientation in native tissue [31,60,61]. This cell-surface interaction directs cellular organization and is essential for the subsequent production of a new ECM with the correct anisotropic properties required for force transmission [38,39,59]. This showcases the link between the scaffold’s physical structure and the cell’s functional outcome, a core principle of rational scaffold design. Biomechanical compatibility A scaffold designed for tendon regeneration must meet the physiologically relevant mechanical properties: tensile strength, elasticity, and flexibility, to withstand the high forces transmitted from muscle to bone. A mismatch in mechanical properties can lead to high stress concentrations at the graft-host interface and eventually risk re-rupture. The concept of ‘mechanical property matching’ is a dynamic requirement. Once a scaffold is implanted, the degradation clock begins. If the scaffold is too stiff for too long, it will bear the majority of the mechanical load, thereby shielding the newly forming cells and matrix from the mechanical stimuli they require to mature and remodel functional tissue [62]. Conversely, if the scaffold is too weak or degrades too quickly, it will fail to provide the mechanical support needed to facilitate proper repair. This highlights a complex, time-dependent design challenge to match the degradation rate of the scaffold to that of tissue formation. As mentioned above, because tendon tissue adapts to its anatomical location and function, biomechanical compatibility benchmarks will vary depending on the target tendon tissue. This further complicates the engineering problem and motivates the need for ‘tuning’ of scaffold strategies, so they are optimized to the application in question. Biocompatibility and host integration Beyond structural and mechanical considerations, a scaffold must be highly biocompatible and facilitate graft integration and regeneration of native tissue. Biocompatibility encompasses more than simply avoiding a negative immune response; it involves the design of an active pro-regenerative microenvironment. Given the low cellularity of native tendon tissue, the integration of cellular components into scaffolds is a critical strategy to enhance regeneration. Mesenchymal stem cells (MSCs) are particularly promising due to their proliferative and immunomodulatory activities [63–65], as well as their potential to differentiate into tenocytes [66–68]. Sources for these cells include the tendon itself (tendon stem/progenitor cells or TSPCs) [44,69,70], bone marrow (BMSCs) [68,71], and adipose tissue (ASCs) [68,72]. An alternative to MSCs is induced pluripotent stem cells-derived mesenchymal stem cells, iPSCs [73]. The role of these cells is not just to replace lost cells; they also act as ‘biochemical factories’ that secrete paracrine factors to modulate the healing environment. These secreted factors can stimulate resident cells and promote tenogenic differentiation and matrix synthesis [44,70]. However, it is a delicate balance to promote desired cell differentiation while ensuring cells do not differentiate into abnormal tissue (e.g., adipose or bone) as this can promote downstream pathology. Advanced scaffold designs are now actively engineered to modulate the local inflammatory response; some materials are designed to avoid the bulk degradation and chronic inflammation commonly associated with certain polymers, while others explore the inhibition of pro-inflammatory macrophage polarization [63,74,75]. This represents a significant paradigm shift from a passive ‘do no harm’ approach to an active ‘do good’ strategy, with scaffolds intelligently designed to manipulate the microenvironment to create favorable conditions for integration and regeneration. Porosity and mass transport One of tendon tissue’s greatest impediments to self-regeneration is its hypocellular and avascular nature. Therefore, scaffold designs need to be sufficiently porous to facilitate the transport of nutrients and waste, which are necessary for cell survival and proliferation, without compromising strength or stability. This requirement creates a paradox. There needs to be enough space and interconnectivity between pores for cells to attach, proliferate, and infiltrate to produce new ECM, and enough stability to withstand physiological loads. Fabrication techniques like micropatterning, 3D printing, and electrospinning allow for precise control over pore size and interconnectivity, without compromising strength and flexibility. Mechanical stimulation While scaffolds can provide a physical template and biochemical cues, the application of mechanical stimulation, either in a bioreactor or through scaffold design, bridges the gap between in vitro cell culture and the formation of functional, load-bearing tissue. Mechanical forces are essential for regulating stem cell behavior, as they mimic the physical stimuli present during the development of native tissues that can guide the cells’ fate toward specific lineages by influencing mechanotransduction pathways [33,35,67,76,77]. Cyclic stretching can enhance the production of tendon-specific markers and proteins, leading to improved tenogenic differentiation and tissue regeneration outcomes [33,37,67,78]. In the absence of mechanical input, cells cultured on a static scaffold may not mature or produce a functional, aligned ECM [67]. Mechanical stimulation has been shown to promote tenogenic differentiation of stem cells, cell proliferation, migration, alignment, and ECM deposition via complex mechanosignaling pathways. A deeper comprehension of the intricate interactions between mechanical forces and cellular responses could significantly enhance regenerative medicine applications by harnessing the body’s inherent repair mechanisms. Bioreactors are custom-made devices that provide this missing stimulus, subjecting the cell-seeded constructs to dynamic loading that mimics the physiological conditions of tendons in vivo [79,80]. This ‘exercise’ forces the engineered tissue to mature and gain strength, resulting in significantly improved mechanical properties [37,38]. The development of such bioreactors is a powerful demonstration of the interplay between physical forces and biological outcomes, and highlights why the field has moved beyond static culture models. Material selection One of the critical focuses in tendon scaffold engineering is the design and incorporation of biomaterials that can effectively mimic the natural structure and function of tendons. As tendon tissue engineering has been around since the 1980s [81] there are many notable reviews that investigate both synthetic and naturally derived biomaterials [82,83]. Synthetic scaffolds, made from compounds such as polycaprolactone (PCL) [84–86] and polylactide-co-glycolide (PLGA), offer control over material properties but may lack bioactivity. Natural scaffolds derived from collagen [32], gelatin [87,88], and cellulose [89,90] provide inherent bioactivity, although they may present challenges in replicating mechanical properties [82]. In this review, we focus on piezoelectric biomaterials that can influence tendon development through their interaction with mechanosensitive ion channels. Piezoelectric materials can generate electrical charges in response to mechanical deformation that can induce conformational changes in membrane proteins. Specialized materials can be designed to generate electrical fields that can be translated by the cells into biochemical signaling pathways [91]. Electromechanical stimulation (EMS) has been utilized to study piezoelectric response and its impact on scaffold regeneration. EMS has shown sustained tenogenic differentiation capacity relative to mechanical stimulation alone [92]. Piezoelectric behavior is a common property of several polymer families including fluoropolymers, polyureas, polyamides, polypeptides, polysaccharides, and polyesters [91,93–95]. Collagen, cellulose, and silk fibroin – also possess piezoelectric behavior [91,95–98]. Three materials we highlight are decellularized extracellular matrix (dECM), silk fibroin, and poly(l-lactic) acid (PLLA). Decellularized extracellular matrix (dECM) Decellularized extracellular matrix (dECM) scaffolds first started with the exploration of and intent to replicate the intricate microenvironment of native tissues and organs. Therefore, many scientists have asked the question, ‘What happens if we let the cells do the work for us?’ [99–102] Happy cells create their own framework; they produce their own proteins to create their unique extracellular environment [38,58]. However, in order to utilize the composition of these matrices, immunogenic cells will need to be removed. The heart of this technique is to preserve as much of the native as possible, while still being able to utilize the scaffold indeterminately. There are four main treatments to prepare dECM scaffolds: chemical, enzymatic, physical, and advanced. Chemical treatments utilize surfactants, acid and base reagents, ionic & nonionic detergents, organic solvents, or chelators to dissolve intercellular bonds and lyse cells by disrupting the membrane phospholipid bilayers, while preserving ECM function and structure. Enzymatic treatments employ nucleases, proteases, etc., to break down cellular bonds and facilitate cell removal. Freeze-thaw cycling, perfusion, sonication, electroporation, agitation, scraping, and pressure gradients are common physical treatments to remove cells from tissues. Physical treatments alone can be too harsh and are often coupled with chemical or enzymatic agents to improve dECM preservation. Newer approaches include vacuum-assisted or apoptosis-assisted decellularization, or supercritical fluids such as carbon dioxide, to eliminate DNA and reduce phospholipid content in tissues. Once the decellularization process is complete, either the whole matrix can be transplanted or lyophilized into powder to create hydrogels and bio-inks for more intricate assembly [29,103]. Silk fibroin Silk fibroin has become a popular natural biomaterial, especially in tendon research, owing to its structure, strength, flexibility, and inherent piezoelectric nature [92,96]. Silk fibroin has a triple helix structure, similar to collagen, and amorphous and crystalline regions that together provide unique mechanical properties. These mechanical and piezoelectric properties can be fine-tuned through various processing techniques, allowing researchers to create scaffolds of various forms such as films [69,104], sponges [105], and fibers [106,107]. These different forms allow tailored applications that closely mimic the mechanical characteristics of native tendon tissue, where the alignment and organization of collagen fibers are crucial for their function. Moreover, the biocompatibility and biodegradability of silk fibroin make it an attractive option for long-term implantation and gradual integration with native tissues. Silk fibroin can be functionalized with bioactive molecules and growth factors to enhance cell adhesion, proliferation, and differentiation [69,92,106,108]. Poly(l-lactic acid) (PLLA) A popular synthetic polymer derived from biological materials for tendon engineering is Poly(l-lactic acid) (PLLA). Similar to silk fibroin, PLLA can exist in amorphous or semi-crystalline forms, dependent on the molecular conformation and the arrangement of polymer chains. PLLA has three main crystalline forms: α, β, and γ, depending on the polymer’s preparation conditions [109]. The PLLA molecule exhibits a helical conformation due to its chirality, and simply aligning the polymer chains is sufficient to remove any center of symmetry and permit shear modes of piezoelectricity [94]. Applying shear strain to a PLLA scaffold through bending, tension, or torsion activates the piezoelectric effect and induces an electric potential and vice versa [93]. Lovell et al. demonstrated the piezoelectric coefficient of stretched and annealed PLLA films is proportional to the chain orientation and degree of crystallinity [110]. However, if the degree of crystallinity and chain orientation is too high, it can lead to poor mechanical properties [110,111]. Processing techniques such as cold drawing, annealing, electrospinning, meltspinning, and fused deposition modeling (FDM) have been utilized to control molecular chain orientation. Therefore, fabrication techniques are crucial to finetune the desired properties of the biomaterials as well as the overall scaffold. Fabrication techniques As we have established: structure begets function; therefore, the processing techniques are crucial. In order for clinical translation, scaffolds need to be reproducible with precise and consistent outcomes. The most common techniques for tendon scaffold fabrication with micro and nano topographies include micropatterning, 3D printing, and electrospinning. Micropatterning Lithography refers to a print-making process that transfers patterns onto surfaces. In photolithography (PL), a silicon substrate is coated with a target metal and a photoresist. This photoresist layer gets selectively exposed to UV light in a desired pattern; as the entire substrate is immersed in a chemical developer, the UV treated parts become soluble and the desired pattern, now dubbed a rigid “master,” remains. Photolithography was originally employed in the semiconductor industry and has been adapted for biomedical applications such as developing complex tissue structures’ biomimetic environments, lab-on-chip applications, and biosensors and bioelectronic devices (e.g., glucose & DNA sensors, neural interfaces, etc.) [112–114]. It was applications like these that created a need for flexible master stamps, which in turn created Soft Lithography (SL). Polydimethylsiloxane (PDMS), a silicone polymer, is poured over top a rigid master to create an elastomeric stamp. This stamp extends the possibilities of conventional photolithography and has developed its own category of substrates for microfluidics, replica molding, capillary molding, microcontact printing, and microtransfer molding. Nanoimprint lithography (NIL) creates stamps from soft or hard polymers, which are pressed into a substrate previously spin-coated with a polymer resist. The polymer fills the stamp and replicates its pattern, providing rapid, high-resolution and high-throughput nanopatterning. Photolithography is a foundational technique in micropatterning, but is often expensive and requires specialized equipment, making it less accessible. Extrapolated lithographic techniques include x-ray (XRL), focused ion beam (FIBL), electron beam (EBL), scanning probe (SPL), multi-photon (MPL), near-field electrospinning-assisted (NFEAL) and magnetolithography (ML) [114]. NFEAL fabricates groove patterns with sub micrometer-scale widths from nano/microfibers deposited onto a polymer substrate as a sacrificial template, polystyrene (PS) was poured over and cured to create the scaffold, and as the fibers were removed with water, the microgrooves remained. This approach successfully employed topographical guidance to enhance directional growth and elongation of myoblast cells [115]. Micropatterned silk fibroin film activated focal adhesion kinase (FAK) and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways and induced the expression of Scx, tenasin-C, Tnmd, and COL1a1 in TSPCs in vivo rat Achilles tendon injury model [69]. Integrins α2β1 were found to be the main TSPCs surface sensors for the micropatterned SF film group [69]. H&E staining and IHC confirmed micropatterned SF film as the most successful group, as both showed more orderly aligned collagen fibers and higher expression of tendon markers in the regenerated Achilles tendons at both 4 and 8 weeks after injury [69]. Expression of talin, paxillin, and actin via FAK/actin pathways was promoted in the TSPCs on micropatterned SF. Talin and paxillin are downstream effectors of integrins that transmit mechanical stimulation from the ECM to cells. Actin regulates morphological changes of TSPCs through the α2β1/FAK/PI3K/AKT/mTORC2 signaling cascade, while the α2β1/FAK/PI3K/AKT/mTORC1 signaling regulates gene transcription and translation. Together, the micropatterned SF film promoted the tenogenic differentiation of TSPCs in vitro and tendon repair in vivo through physical signal transmission [69]. One group leveraged the innate mechanical properties of silk fibroin’s polymer structure and directional freeze-casting to micropattern an oriented cryostructured silk fibroin bandage (OCSFB) that replicates the highly organized collagen fiber architecture of native tendon [116]. The OCSFB was fabricated by directional freeze-casting in custom molds fabricated by fused deposition modeling at −90°C and compared to an unoriented conventional isotropic freezing (UCSFB) as a control. Both OCSFB and UCSFB were crosslinked with ethanol to increase silk fibroin’s β-sheet formation and then compressed into a bandage. OCSFB structural organization and biological performance were validated in vitro and in vivo rat Achilles tendon injury model. After 7 days in vitro, immunofluorescence staining confirmed OCSFB had significantly higher COL1 and COL3 expression, as well as an increase in mechanosensitive regulators Yap1 and TAZ. mRNA expression levels COL1a1, COL3a1, TNC, and TNMD were also significantly higher after 7 days in vitro. Four weeks post scaffold implantation in vivo rat Achilles tendon injury model, the OCSFB group demonstrated dense, aligned collagen fibers and minimal scar tissue. The scaffold’s inflammatory response included significantly lower CD68-positive macrophages and MPO-positive neutrophils and increased CD206-positive M2 macrophages, indicating favorable polarization toward an anti-inflammatory phenotype. Gait analysis and mechanical strength assessment corroborate a progressive normalization compared to the native group by 14 and 28 days, and a significantly higher tensile modulus [116]. Taken together, a highly aligned and porous silk fibroin scaffold successfully facilitated mechanical and immunomodulatory responses. 3D-Printing Versatility and precision are the key characteristics that have dubbed 3D printing as the most tunable and personalized technique yet, as it can adjust structures to precisely match a patient’s anatomy or injury specifics. In its most pure definition bioprinting can be defined as translating a digital design into a tangible structure by depositing biomaterials or bioink in controlled layers. The most common forms of bioprinting include inkjet, extrusion-based, stereolithography (SLA), laser-assisted (LAB), and fused deposition modeling (FDM) [117]. Emerging techniques Digital Light Processing (DLP) and volume printing have potential to allow for high-resolution and rapid fabrication of these complex structures needed to mimic and replace detailed tissue constructs. The selection of biomaterial and bioink is paramount to success in 3D printing. Bioinks were designed to improve biocompatibility, immunogenic responses, cell attachment, proliferation, and differentiation, as well as viscoelasticity, mechanical stability, porosity, and anisotropy. Many bioinks include natural polymers like alginate, collagen, chitosan, fibrin, hyaluronic acid, and gelatin to mimic native ECM and stimulate cell-matrix interactions. However, synthetic polymers have also been researched on their own and in combination with natural polymers to achieve desired strength and integration. Other enhancements in 3D printing include nozzle choice. One group printed PCL through a custom-made nozzle patterned with a circumferential sinusoidal wave to generate uniaxial microgrooves along the extruded filaments [73]. Microgrooved scaffolds induced greater cellular alignment and up-regulation of tenogenic markers COL1A1, TNC, MKX, and TNMD in iMSC SCX+ cells in vitro compared to 2D culture and non-patterned scaffolds. Analysis of microgrooved scaffolds explanted from rat Achilles tendon subjects confirmed improved biomechanical properties compared to scaffold only or suture only groups [73] This research demonstrates the ability to combine contact guidance with extrusion 3D printing to enhance the utility of both and promote functional tendon regeneration. Electrospinning Electrospinning is a very attractive approach for tendon engineering, as it has many tunable variables to customize scaffolding. Process variables include humidity, temperature, distance, applied voltage, flow rate, and the collector, while solution variables entail polymer selection, concentration, viscosity, molecular weight, solvent volatility, and molecular structure. All these variables can influence fiber generation and nanostructure, which, as structure informs function, the fibers’ shape and size inform morphology, migration, and differentiation [118,119]. These cellular responses to fiber parameters have been studied in a few different ways, but integrating them is still an ongoing process for regenerative engineers [31,120,121]. Electrospinning can be modified in many ways, but the most impactful variable is the collector. Collectors range from flat sheets of conductive metal to rotating cylinders, and many clever tricks in between to achieve “random,” “aligned,” and “woven” patterns, as shown in Figure 3. Electrospinning allows a solubilized polymer to follow a current from syringe tip to the collector, materializing and filling the space on the way, add in a magnetic field via solution and/or collector and there is an entirely new element to the playing field. All these adjustments can be manipulated and refined to create desired structures to mimic native tissue [60,84,122,123]. Figure 3.Common components for different types of Electrospinning. A. Typical electrospinning setup used to produce random fiber orientation, including the syringe pump, power source, and a flat collector; B. Rotating drum collector to be used in place of a flat collector to produce aligned fibers. C. The electrospinning setup for yarn preparation. D. A common braiding machine to create braided, textile, or woven scaffolds. Figure made with Mind the Graph.The image A showing an electrospinning setup for random fibers, including a syringe pump, power source and flat collector. The fibers are depicted as randomly oriented. The image B showing an electrospinning setup for aligned fibers, featuring a rotating drum collector. The fibers are shown as aligned. The image C showing an electrospinning setup for yarn preparation, with two syringe pumps labeled as positive and negative voltage, a fiber collector and a yarn collector. The fibers are arranged to form yarn. The image D showing a braiding machine used to create braided, textile, or woven scaffolds. The machine is depicted alongside the braided fibers it produces.Diagrams: electrospinning setups for random/aligned fibers, yarn prep and braiding machine. Common components for different types of Electrospinning. A. Typical electrospinning setup used to produce random fiber orientation, including the syringe pump, power source, and a flat collector; B. Rotating drum collector to be used in place of a flat collector to produce aligned fibers. C. The electrospinning setup for yarn preparation. D. A common braiding machine to create braided, textile, or woven scaffolds. Figure made with Mind the Graph. Textile and woven scaffolds Hierarchical fibrous scaffolds are typically comprised of nanoscale fibers arranged in larger macroscale structures. Nanofibers can be augmented by custom electrospinning devices mentioned above, or combined with yarn spinning techniques such as twisting, drawing, and winding to create nanoyarns [32,61,74,86,121,124,125]. Traditional textile manufacturing methods like plying, braiding, knitting, and weaving can then be utilized to create complex 3D hierarchical structures [32,61,63,121]. These strategies have been around for at least two decades now, and are not limited to tendon scaffold regeneration, as they have demonstrated great promise in other hierarchical structures such as nerve [126], ligament [105,127], bone [128], and cardiovascular [129] tissue. PLLA and SF/PLLA hybrid nanoyarns were fabricated via a modified electrospinning device with one yarn-forming unit and one hot stretching unit. Woven fabrics were constructed by an SGA598 semi-automatic weaving machine with custom nmPLLA (460 nm diameter) or nmSF/PLL (378 nm diameter) nanoyarns as the warp, and commercial mmPLLA yarn (188 µm diameter) as the weft [63]. Scaffolds were seeded with tenocytes harvested from rat superficial flexor tendons for in vitro studies that confirmed increased adhesion, proliferation, and phenotypic maintenance of tenocytes on nmSF/PLLA scaffolds in comparison to both nmPLLA and mmPLLA. Furthermore, a significant increase in M2 macrophages (CD163-positve cells) was observed in nanometer scaffolds over the mmPLLA, with the nmSF/PLLA scaffold significantly higher than nmPLLA alone. Melt Electrowriting (MEW) additive manufacturing Melt Electrowriting (MEW) is a recent expansion upon 3D printing and electrospinning. It is an additive manufacturing technique to create precise highly defined 3D scaffolds, the perfect environment needed to support tendon tissue formation. Fibrous tubular PCL scaffolds were manufactured by a custom-built MEW device with controlled nozzle movement that deposited fibers onto a rotating mandrel in the longitudinal direction [130]. Fiber diameter of final constructs could be consistently tuned between 10 and 50 µm, which puts them in the collagen fiber crimp waveform range of the collagen:tendon hierarchy. Combined strategies Many current tendon scaffold designs have evolved to include an insertion site (MTJ or TBI), enthesis for better holistic integration. The core concept of these designs is to mimic the continuous, graded changes in structure, composition, and mechanical properties from the flexible tendon end to muscle insertion (MTJ) or the rigid bone end (TBI) [85,95–97]. One example utilizes a 3D printed collector to “combine both gap-spinning and micropatterning to create a smooth gradient of 5 mm long from honeycomb structure to aligned fibers (promoting bone and tendon fate, respectively) in a single step” [85]. Mineralization has been used to mimic the transition from soft tissue to fibrocartilage to bone [91,95,98–100]. These advanced scaffold designs aim to replicate the complex structure and functionality of the native tendon-to-bone interface. By incorporating gradients in both structure and composition, researchers hope to improve the integration and regeneration of the tissue at the insertion site. Such biomimetic approaches may lead to more effective treatments for tendon injuries and disorders. One research group created the multiscale biomimetic tendon (MBT) scaffold, which consists of a shell and core designed to mimic the natural tendon hierarchy from nano to macro scale [54]. The core of the scaffold is made up of PCL microscale wave fibers, to mimic the helical pattern of tendon collagen fibers (40–60 µm) and five layers of crimped fibers (5–10 µm), that were created and layered via MEW. These layers were designed to provide structural support and absorb deformation under radial tension to recapitulate the mechanical structure of native tendon. Fused deposition modeling (FDM) through a rotational printing process was used to create a porous shell to act as the tendon sheath. The core fiber layers were rolled into a tube shape and encased in gelatin-methacrylol (GelMA) before inserting it into the shell. GelMA is a popular hydrogel to improve cell adhesion and proliferation due to its abundant tripeptide RGD (Arg-Gly-Asp) sequences, similar to collagen, that mediate cell attachment [131]. Overall, the work proposes a biomimetic scaffold that integrates structural and functional cues from native tendon tissue to promote rapid regeneration of a full-thickness tendon injury in rabbit patella tendons. A self-powered piezo-bioelectric device fabricated from electrospun silk fibroin fibers, enhanced silk fibroin’s inherent piezoelectric properties through cold drawing and mechanical stimulation, and demonstrated the bioelectric cues significantly influenced tendon tissue-repair signaling pathways by modulating mechanosensitive ion channels [92]. The silk fibroin scaffold was compared directly to an electrically inert scaffold made from PTFE as a non-piezoelectric control. Electromechanical stimulation (EMS) resulted in the maintenance of tendon phenotype, with significantly increased collagen I/III synthesis, deactivated BMP signaling, and upregulated SCX and TNMD proteins, relative to only mechanical stimulation (MS). MS alone sustained BMP signaling, increased expression of ion channels, and lost tendon specificity in cell populations in vitro. Together, this work highlights the crucial roles mechanical and electromechanical stresses play in tendon cell function and tissue repair processes. PLLA and nano-hydroxyapatite (nHA) were electrospun to fabricate a nanofibrous scaffold to investigate how nHA effects fiber alignment and piezoelectric phases and piezoelectricity of PLLA samples. nHA showed no significant impact on the morphology of the spun nanofibers and their alignment for different rotational speeds, 100 rpm was used for random and 2000 rpm for aligned fibers. PLLA fibers loaded with nHA increased water uptake with an increased porosity by 7–9% compared to unloaded fibers. Rotational speed of the collector and nHA addition both affected the piezoelectric constant (d33) of the material. d33 was found to increase from 4.04 pCN−1 to 4.42 pCN−1 (random, 100 rpm) and 4.58 pCN−1 to 4.68 pCN−1 (aligned, 2000 rpm) with the nHA addition. This confirms when the fibers are aligned and better mimic the anisotropic nature of native tissue, the piezoelectric dipoles are oriented in a uniform direction, which results in a more efficient conversion of mechanical stress into electrical signals [109]. Future perspective Based on the current state of the field and the challenges that remain, the following recommendations are put forth for future research and development: Explore Next-Gen Bioreactors: Developing bioreactors that can precisely replicate the complex, multi-angle mechanical forces of native tendons is critical for better validation of scaffold performance in vitro. This would allow for more rigorous testing of material and design choices before moving to costly and time-consuming in vivo studies. Investigate Combination Therapies: Future studies should focus on combination therapies that incorporate multiple growth factors, cells, and mechanical stimuli to address the complexity of the healing process in a comprehensive manner. Standardize Outcome Measures: The field lacks standardized scaffold designs and manufacturing protocols. Establishing these standards would facilitate head-to-head comparisons of different approaches and streamline the process for regulatory approval, accelerating the pace of innovation. Focus on Large Animal Models: The critical need for more robust preclinical data from large animal models to bridge the lab-to-clinic gap is clear. While a scaffold may show promising results in a petri dish or a small animal model, scaling it up to large animal models, where mechanical forces and biological environments are closer to humans, often reveal shortcomings in durability and biological response. Therefore, these models can better simulate the mechanical forces and biological responses seen in humans, providing a more reliable foundation for clinical translation. Achieving widespread clinical adoption requires more than just scientific breakthroughs; it requires overcoming significant translational and regulatory hurdles. The path forward involves continued collaboration between material scientists, biologists, engineers, and clinicians. This multidisciplinary approach will be essential for creating devices that are not only scientifically sound but also surgically manageable, manufacturable, and cost-effective. There is a significant hurdle that remains in translating promising laboratory results into routine clinical practice. Regulatory requirements, the scaling of scaffold production while maintaining consistency and quality, and the complexity of supply chains for advanced manufacturing techniques pose additional challenges. The production and widespread implementation of these therapies require adherence to stringent regulatory standards, which can be a long, resource-intensive process. The typical academic research paradigm, which often prioritizes publication over product development, may not align with the business model necessary for clinical translation. This misalignment can impact funding priorities and publishing practices, potentially hindering the progress of scaffold therapies from laboratories to market. Moreover, most research has been overwhelmingly focused on preclinical studies, primarily using smaller animal models, which cannot replicate human clinical conditions, thus prolonging the translational journey. artnerships through industrious research companies with academic labs or universities could be an excellent way to navigate many constraints in the regenerative medicine space. Industry partners can support up-and-coming academics as they gain experience with the specialized tools and equipment of a specific field, while simultaneously training the next generation of leading researchers and engineers within their companies. The design of scaffolds for tendon regenerative medicine is a complex, interdisciplinary challenge that has evolved from a simple structural replacement to a sophisticated, bio-instructive strategy. This review has detailed the fundamental biological and mechanical properties of native tendon, highlighted the limitations of current treatments, and established the foundational principles for a truly biomimetic scaffold. The analysis of materials, fabrication techniques, and functionalization strategies demonstrates a clear trend toward a synergistic, integrated design. The future of the field lies in the development of intelligent scaffolds that combine advanced materials and active biological and mechanical stimuli, with the ultimate goal of achieving a complete, functional regeneration of native tissue. While significant hurdles remain in replicating the intricate tendon-to-bone interface and navigating the clinical translation process, the convergence of these innovative disciplines offers a powerful path toward a new era of tendon regenerative medicine.